Bunge Reports Third Quarter 2023 Results
- Bunge reports Q3 2023 GAAP diluted EPS of $2.47, showing a slight decrease from the prior year. However, on an adjusted basis, the company saw higher results in Processing. The progress made on the Viterra transaction is expected to accelerate Bunge's growth. The company has also repurchased approximately $600 million of common shares since Q2. The full-year adjusted EPS outlook has been increased to at least $12.50.
- None.
-
Q3 GAAP diluted EPS of
$2.47 $2.49 $2.99 $3.45 - In Agribusiness higher Processing results were more than offset by lower results in Merchandising
-
Higher Refined and Specialty Oils results driven by strength in
North America - Significant progress on Viterra transaction and other growth initiatives
-
Repurchased
~ of common shares since Q2$600 million -
Increasing full-year adjusted EPS outlook to at least
$12.50
- Overview
Greg Heckman, Bunge’s Chief Executive Officer, commented, “Our team remained focused on executing our day-to-day business to deliver strong results for the third quarter. Our operating model enabled us to maximize our global footprint as we responded effectively to shifting market conditions. At the same time, we reached an important milestone in our strategic combination with Viterra, achieving overwhelming shareholder support for the transaction that we expect to accelerate Bunge’s growth.
“We are also making good progress on other growth initiatives including enhancing our footprint, building relationships with our customers – farmers and end consumers, and strengthening our digital capabilities. I am proud of our team’s work across value chains to successfully deliver on our mission of connecting farmers to consumers to deliver essential food, feed and fuel to the world.”
- Financial Highlights
|
Three Months Ended
|
|
Nine Months Ended
|
||||||||||
(US$ in millions, except per share data) |
|
2023 |
|
|
2022 |
|
|
|
2023 |
|
|
2022 |
|
Net income attributable to Bunge |
$ |
373 |
|
$ |
380 |
|
|
$ |
1,627 |
|
$ |
1,274 |
|
Net income per common share-diluted |
$ |
2.47 |
|
$ |
2.49 |
|
|
$ |
10.71 |
|
$ |
8.30 |
|
|
|
|
|
|
|
||||||||
Mark-to-market timing differences (a) |
$ |
0.14 |
|
$ |
0.19 |
|
|
$ |
(1.29 |
) |
$ |
1.04 |
|
Certain (gains) & charges (b) |
$ |
0.38 |
|
$ |
0.77 |
|
|
$ |
0.55 |
|
$ |
1.32 |
|
Adjusted Net income per common share-diluted (c) |
$ |
2.99 |
|
$ |
3.45 |
|
|
$ |
9.97 |
|
$ |
10.66 |
|
|
|
|
|
|
|
||||||||
Core Segment EBIT (c) (d) |
$ |
711 |
|
$ |
628 |
|
|
$ |
2,674 |
|
$ |
1,959 |
|
Mark-to-market timing differences (a) |
|
34 |
|
|
36 |
|
|
|
(261 |
) |
|
193 |
|
Certain (gains) & charges (b) |
|
(10 |
) |
|
76 |
|
|
|
(29 |
) |
|
156 |
|
Adjusted Core Segment EBIT (c) |
$ |
735 |
|
$ |
740 |
|
|
$ |
2,384 |
|
$ |
2,308 |
|
|
|
|
|
|
|
||||||||
Corporate and Other EBIT (c) |
$ |
(182 |
) |
$ |
(84 |
) |
|
$ |
(417 |
) |
$ |
(238 |
) |
Certain (gains) & charges (b) |
|
68 |
|
|
11 |
|
|
|
102 |
|
|
(18 |
) |
Adjusted Corporate and Other EBIT (c) |
$ |
(114 |
) |
$ |
(73 |
) |
|
$ |
(315 |
) |
$ |
(256 |
) |
|
|
|
|
|
|
||||||||
Non-core Segment EBIT (c) (e) |
$ |
55 |
|
$ |
24 |
|
|
$ |
125 |
|
$ |
63 |
|
Certain (gains) & charges (b) |
|
— |
|
|
— |
|
|
|
— |
|
|
— |
|
Adjusted Non-core Segment EBIT (c) |
$ |
55 |
|
$ |
24 |
|
|
$ |
125 |
|
$ |
63 |
|
|
|
|
|
|
|
||||||||
Total Segment EBIT (c) |
$ |
584 |
|
$ |
568 |
|
|
$ |
2,382 |
|
$ |
1,784 |
|
Mark-to-market timing differences (a) |
|
34 |
|
|
36 |
|
|
|
(261 |
) |
|
193 |
|
Certain (gains) & charges (b) |
|
58 |
|
|
87 |
|
|
|
73 |
|
|
138 |
|
Adjusted Total Segment EBIT (c) |
$ |
676 |
|
$ |
691 |
|
|
$ |
2,194 |
|
$ |
2,115 |
|
(a) |
Mark-to-market timing impact of certain commodity and freight contracts, readily marketable inventories, and related hedges associated with committed future operating capacity. See note 3 in the Additional Financial information section of this release for details. |
|
(b) |
Certain (gains) & charges included in Total Segment EBIT. See Additional Financial Information for details. |
|
(c) |
Core Segment EBIT, Adjusted Core Segment EBIT, Corporate and Other EBIT, Adjusted Corporate and Other EBIT, Non-core Segment EBIT, Adjusted Non-core Segment EBIT, Total Segment EBIT, Adjusted Total Segment EBIT, and Adjusted Net income per common share-diluted are non-GAAP financial measures. Reconciliations to the most directly comparable |
|
(d) |
Core Segment earnings before interest and tax ("Core Segment EBIT") comprises the aggregate earnings before interest and tax (“EBIT”) of Bunge’s Agribusiness, Refined and Specialty Oils and Milling reportable segments, and excludes Bunge's Sugar & Bioenergy reportable segment and Corporate and Other activities. |
|
(e) |
Non-core Segment EBIT comprises Bunge’s Sugar & Bioenergy reportable segment EBIT, which reflects Bunge's share of the results of its 50/50 joint venture with BP p.l.c. |
- Third Quarter Results
Core Segments
Agribusiness
|
Three Months Ended |
|
Nine Months Ended |
||||||||||
(US$ in millions, except per share data) |
Sep 30, 2023 |
Sep 30, 2022 |
|
Sep 30, 2023 |
Sep 30, 2022 |
||||||||
Volumes (in thousand metric tons) |
|
18,854 |
|
|
19,622 |
|
|
|
55,497 |
|
|
59,182 |
|
|
|
|
|
|
|
||||||||
Net Sales |
$ |
10,082 |
|
$ |
11,741 |
|
|
$ |
31,809 |
|
$ |
35,719 |
|
|
|
|
|
|
|
||||||||
Gross Profit |
$ |
645 |
|
$ |
632 |
|
|
$ |
2,450 |
|
$ |
1,812 |
|
|
|
|
|
|
|
||||||||
Selling, general and administrative expense |
$ |
(145 |
) |
$ |
(135 |
) |
|
$ |
(428 |
) |
$ |
(375 |
) |
|
|
|
|
|
|
||||||||
Foreign exchange gains (losses) |
$ |
(52 |
) |
$ |
(35 |
) |
|
$ |
(77 |
) |
$ |
(119 |
) |
|
|
|
|
|
|
||||||||
EBIT attributable to noncontrolling interests |
$ |
(9 |
) |
$ |
3 |
|
|
$ |
(29 |
) |
$ |
(14 |
) |
|
|
|
|
|
|
||||||||
Other income (expense) - net |
$ |
36 |
|
$ |
6 |
|
|
$ |
54 |
|
$ |
(71 |
) |
|
|
|
|
|
|
||||||||
Income (loss) from affiliates |
$ |
(14 |
) |
$ |
10 |
|
|
$ |
(19 |
) |
$ |
41 |
|
|
|
|
|
|
|
||||||||
Segment EBIT |
$ |
461 |
|
$ |
481 |
|
|
$ |
1,951 |
|
$ |
1,274 |
|
Mark-to-market timing differences |
|
21 |
|
|
26 |
|
|
|
(264 |
) |
|
167 |
|
Certain (gains) & charges |
|
(10 |
) |
|
21 |
|
|
|
(29 |
) |
|
101 |
|
Adjusted Segment EBIT |
$ |
472 |
|
$ |
528 |
|
|
$ |
1,658 |
|
$ |
1,542 |
|
|
|
|
|
|
|
||||||||
Certain (gains) & charges, Net income (loss) attributable to Bunge |
$ |
(9 |
) |
$ |
21 |
|
|
$ |
(25 |
) |
$ |
89 |
|
Certain (gains) & charges, Earnings per share |
$ |
(0.06 |
) |
$ |
0.14 |
|
|
$ |
(0.17 |
) |
$ |
0.59 |
|
Processing (2)
|
Three Months Ended |
|
Nine Months Ended |
||||||||
(US$ in millions) |
Sep 30, 2023 |
Sep 30, 2022 |
|
Sep 30, 2023 |
Sep 30, 2022 |
||||||
Processing EBIT |
$ |
430 |
|
$ |
344 |
|
$ |
1,653 |
|
$ |
907 |
Mark-to-market timing differences |
|
(2 |
) |
|
55 |
|
|
(281 |
) |
|
132 |
Certain (gains) & charges |
|
(4 |
) |
|
21 |
|
|
(18 |
) |
|
73 |
Adjusted Processing EBIT |
$ |
424 |
|
$ |
420 |
|
$ |
1,354 |
|
$ |
1,112 |
Higher results in
Merchandising (2)
|
Three Months Ended |
|
Nine Months Ended |
|||||||||
(US$ in millions) |
Sep 30, 2023 |
Sep 30, 2022 |
|
Sep 30, 2023 |
Sep 30, 2022 |
|||||||
Merchandising EBIT |
$ |
31 |
|
$ |
137 |
|
|
$ |
298 |
|
$ |
367 |
Mark-to-market timing differences |
|
23 |
|
|
(29 |
) |
|
|
17 |
|
|
35 |
Certain (gains) & charges |
|
(6 |
) |
|
— |
|
|
|
(11 |
) |
|
28 |
Adjusted Merchandising EBIT |
$ |
48 |
|
$ |
108 |
|
|
$ |
304 |
|
$ |
430 |
Higher results in our global corn value chain, which benefited from the large Brazilian safrinha corn crop, was more than offset by lower results in financial services and our global wheat value chain.
Refined & Specialty Oils
|
Three Months Ended |
|
Nine Months Ended |
||||||||||
(US$ in millions, except per share data) |
Sep 30, 2023 |
Sep 30, 2022 |
|
Sep 30, 2023 |
Sep 30, 2022 |
||||||||
Volumes (in thousand metric tons) |
|
2,278 |
|
|
2,316 |
|
|
|
6,636 |
|
|
6,941 |
|
|
|
|
|
|
|
||||||||
Net Sales |
$ |
3,601 |
|
$ |
4,302 |
|
|
$ |
11,090 |
|
$ |
12,723 |
|
|
|
|
|
|
|
||||||||
Gross Profit |
$ |
352 |
|
$ |
232 |
|
|
$ |
1,027 |
|
$ |
819 |
|
|
|
|
|
|
|
||||||||
Selling, general and administrative expense |
$ |
(98 |
) |
$ |
(86 |
) |
|
$ |
(291 |
) |
$ |
(262 |
) |
|
|
|
|
|
|
||||||||
Foreign exchange gains (losses) |
$ |
(2 |
) |
$ |
(6 |
) |
|
$ |
8 |
|
$ |
(14 |
) |
|
|
|
|
|
|
||||||||
EBIT attributable to noncontrolling interests |
$ |
(6 |
) |
$ |
(3 |
) |
|
$ |
(17 |
) |
$ |
(7 |
) |
|
|
|
|
|
|
||||||||
Other income (expense) - net |
$ |
(19 |
) |
$ |
(9 |
) |
|
$ |
(50 |
) |
$ |
(17 |
) |
|
|
|
|
|
|
||||||||
Segment EBIT |
$ |
227 |
|
$ |
128 |
|
|
$ |
677 |
|
$ |
519 |
|
Mark-to-market timing differences |
|
3 |
|
|
12 |
|
|
|
(6 |
) |
|
15 |
|
Certain (gains) & charges |
|
— |
|
|
55 |
|
|
|
— |
|
|
55 |
|
Adjusted Segment EBIT |
$ |
230 |
|
$ |
195 |
|
|
$ |
671 |
|
$ |
589 |
|
|
|
|
|
|
|
||||||||
Certain (gains) & charges, Net income (loss) attributable to Bunge |
$ |
— |
|
$ |
55 |
|
|
$ |
— |
|
$ |
55 |
|
Certain (gains) & charges, Earnings per share |
$ |
— |
|
$ |
0.36 |
|
|
$ |
— |
|
$ |
0.36 |
|
Refined & Specialty Oils Summary
Higher results in the quarter were primarily driven by
Milling
|
Three Months Ended |
|
Nine Months Ended |
||||||||||
(US$ in millions, except per share data) |
Sep 30, 2023 |
Sep 30, 2022 |
|
Sep 30, 2023 |
Sep 30, 2022 |
||||||||
Volumes (in thousand metric tons) |
|
890 |
|
|
1,234 |
|
|
|
2,555 |
|
|
3,537 |
|
|
|
|
|
|
|
||||||||
Net Sales |
$ |
479 |
|
$ |
631 |
|
|
$ |
1,484 |
|
$ |
1,911 |
|
|
|
|
|
|
|
||||||||
Gross Profit |
$ |
50 |
|
$ |
45 |
|
|
$ |
121 |
|
$ |
242 |
|
|
|
|
|
|
|
||||||||
Selling, general and administrative expense |
$ |
(25 |
) |
$ |
(26 |
) |
|
$ |
(70 |
) |
$ |
(78 |
) |
|
|
|
|
|
|
||||||||
Foreign exchange gains (losses) |
$ |
— |
|
$ |
— |
|
|
$ |
(1 |
) |
$ |
2 |
|
|
|
|
|
|
|
||||||||
Other income (expense) - net |
$ |
(2 |
) |
$ |
1 |
|
|
$ |
(5 |
) |
$ |
2 |
|
|
|
|
|
|
|
||||||||
Segment EBIT |
$ |
23 |
|
$ |
19 |
|
|
$ |
46 |
|
$ |
166 |
|
Mark-to-market timing differences |
|
10 |
|
|
(2 |
) |
|
|
9 |
|
|
11 |
|
Certain (gains) & charges |
|
— |
|
|
— |
|
|
|
— |
|
|
— |
|
Adjusted Segment EBIT |
$ |
33 |
|
$ |
17 |
|
|
$ |
55 |
|
$ |
177 |
|
|
|
|
|
|
|
||||||||
Certain (gains) & charges, Net income (loss) attributable to Bunge |
$ |
— |
|
$ |
— |
|
|
$ |
— |
|
$ |
— |
|
Certain (gains) & charges, Earnings per share |
$ |
— |
|
$ |
— |
|
|
$ |
— |
|
$ |
— |
|
Milling Summary
Higher results in the quarter were primarily driven by our South American operations reflecting improved margins due to the combination of lower wheat costs and more favorable channel mix. Results in the
Corporate and Other
|
Three Months Ended |
|
Nine Months Ended |
||||||||||
(US$ in millions, except per share data) |
Sep 30, 2023 |
Sep 30, 2022 |
|
Sep 30, 2023 |
Sep 30, 2022 |
||||||||
Gross Profit |
$ |
(4 |
) |
$ |
(23 |
) |
|
$ |
(11 |
) |
$ |
(15 |
) |
|
|
|
|
|
|
||||||||
Selling, general and administrative expense |
$ |
(178 |
) |
$ |
(90 |
) |
|
$ |
(430 |
) |
$ |
(263 |
) |
|
|
|
|
|
|
||||||||
Foreign exchange gains (losses) |
$ |
6 |
|
$ |
(11 |
) |
|
$ |
5 |
|
$ |
(19 |
) |
|
|
|
|
|
|
||||||||
EBIT attributable to noncontrolling interests |
$ |
1 |
|
$ |
— |
|
|
$ |
2 |
|
$ |
(11 |
) |
|
|
|
|
|
|
||||||||
Other income (expense) - net |
$ |
(7 |
) |
$ |
40 |
|
|
$ |
34 |
|
$ |
71 |
|
|
|
|
|
|
|
||||||||
Income (loss) from affiliates |
$ |
— |
|
$ |
— |
|
|
$ |
(17 |
) |
$ |
(1 |
) |
|
|
|
|
|
|
||||||||
Segment EBIT |
$ |
(182 |
) |
$ |
(84 |
) |
|
$ |
(417 |
) |
$ |
(238 |
) |
Certain (gains) & charges |
|
68 |
|
|
11 |
|
|
|
102 |
|
|
(18 |
) |
Adjusted Segment EBIT |
$ |
(114 |
) |
$ |
(73 |
) |
|
$ |
(315 |
) |
$ |
(256 |
) |
|
|
|
|
|
|
||||||||
Certain (gains) & charges, Net income (loss) attributable to Bunge |
$ |
67 |
|
$ |
41 |
|
|
$ |
109 |
|
$ |
59 |
|
Certain (gains) & charges, Earnings per share |
$ |
0.44 |
|
$ |
0.27 |
|
|
$ |
0.72 |
|
$ |
0.37 |
|
Corporate
|
Three Months Ended |
|
Nine Months Ended |
||||||||||
(US$ in millions) |
Sep 30, 2023 |
Sep 30, 2022 |
|
Sep 30, 2023 |
Sep 30, 2022 |
||||||||
Corporate EBIT |
$ |
(155 |
) |
$ |
(104 |
) |
|
$ |
(381 |
) |
$ |
(262 |
) |
Certain (gains) & charges |
|
48 |
|
|
11 |
|
|
|
66 |
|
|
(18 |
) |
Adjusted Corporate EBIT |
$ |
(107 |
) |
$ |
(93 |
) |
|
$ |
(315 |
) |
$ |
(280 |
) |
Other
|
Three Months Ended |
|
Nine Months Ended |
||||||||
(US$ in millions) |
Sep 30, 2023 |
Sep 30, 2022 |
|
Sep 30, 2023 |
Sep 30, 2022 |
||||||
Other EBIT |
$ |
(27 |
) |
$ |
20 |
|
$ |
(36 |
) |
$ |
24 |
Certain (gains) & charges |
|
20 |
|
|
— |
|
|
36 |
|
|
— |
Adjusted Other EBIT |
$ |
(7 |
) |
$ |
20 |
|
$ |
— |
|
$ |
24 |
Corporate and Other Summary
The increase in Corporate expenses primarily reflected investments in growth initiatives as well as performance related compensation accruals. Lower Other results were primarily related to Bunge Ventures and our captive insurance program.
Non-core Segments
Sugar & Bioenergy
|
Three Months Ended |
|
Nine Months Ended |
||||||
(US$ in millions, except per share data) |
Sep 30, 2023 |
Sep 30, 2022 |
|
Sep 30, 2023 |
Sep 30, 2022 |
||||
Net Sales |
$ |
56 |
$ |
74 |
|
$ |
192 |
$ |
195 |
|
|
|
|
|
|
||||
Gross Profit |
$ |
2 |
$ |
2 |
|
$ |
4 |
$ |
6 |
|
|
|
|
|
|
||||
Income (loss) from affiliates |
$ |
53 |
$ |
20 |
|
$ |
119 |
$ |
56 |
|
|
|
|
|
|
||||
Segment EBIT |
$ |
55 |
$ |
24 |
|
$ |
125 |
$ |
63 |
Certain (gains) & charges |
|
— |
|
— |
|
|
— |
|
— |
Adjusted Segment EBIT |
$ |
55 |
$ |
24 |
|
$ |
125 |
$ |
63 |
|
|
|
|
|
|
||||
Certain (gains) & charges, Net income (loss) attributable to Bunge |
$ |
— |
$ |
— |
|
$ |
— |
$ |
— |
Certain (gains) & charges, Earnings per share |
$ |
— |
$ |
— |
|
$ |
— |
$ |
— |
Sugar & Bioenergy Summary
Improved results were primarily driven by higher sugar prices, which more than offset lower ethanol prices.
Cash Flow
|
Nine Months Ended |
|||||
|
Sep 30, 2023 |
Sep 30, 2022 |
||||
Cash provided by (used for) operating activities |
$ |
1,860 |
|
$ |
(5,031 |
) |
Proceeds from beneficial interest in securitized trade receivables (a) |
|
85 |
|
|
5,176 |
|
Cash provided by (used for) operating activities, adjusted |
$ |
1,945 |
|
$ |
145 |
|
Certain reconciling items to Adjusted funds from operations (4) |
|
(10 |
) |
|
1,643 |
|
Adjusted funds from operations (4) |
$ |
1,935 |
|
$ |
1,788 |
|
(a) |
On November 16, 2022, Bunge and certain of its subsidiaries amended its trade receivables securitization program from a deferred purchase price ("DPP") structure to a pledge structure. Prior to November 16, 2022, Bunge received a portion of its consideration in the form of beneficial interests in securitized trade receivables. Cash collections of the beneficial interests were classified as investing activities in the consolidated statements of cash flows. Subsequent to November 16, 2022, all consideration is received in cash and classified as an operating activity in the consolidated statements of cash flows, except for transition-related collections of repurchased receivables which are reported as investing activity in Proceeds from beneficial interest in securitized trade receivables in the consolidated statements of cash flows. |
Cash provided by operations in the nine months ended September 30, 2023, was
Income Taxes
For the nine months ended September 30, 2023, income tax expense was
- Outlook(5)
Taking into account year-to-date results and the current margin environment and forward curves, we now expect full-year 2023 adjusted EPS of at least
In Agribusiness, full-year results are expected to be up from our prior outlook and in line with last year driven by higher results in Processing.
In Refined and Specialty Oils, full-year results are expected to be up from our prior outlook and last year's record performance.
In Milling, full-year results are expected to be in line with our prior outlook and significantly down from a strong prior year.
In Corporate and Other, results are expected to be down from our prior forecast and last year.
In Non-Core, full-year results in our sugar and bioenergy joint venture are expected to be up from our prior outlook and higher than last year.
Additionally, the Company expects the following for 2023: an adjusted annual effective tax rate in the range of
- Conference Call and Webcast Details
Bunge Limited’s management will host a conference call at 8:00 a.m. Eastern (7:00 a.m. Central) on Thursday, October 26, 2023 to discuss the Company’s results.
Additionally, a slide presentation to accompany the discussion of results will be posted on www.bunge.com.
To access the webcast, go to “Events & Presentations” under “News & Events” in the “Investor Center” section of the company’s website. Select “Q3 2023 Bunge Limited Conference Call” and follow the prompts. Please go to the website at least 15 minutes prior to the call to register and download any necessary audio software.
To listen to the call, please dial 1-844-735-3666. If you are located outside
A replay of the call will be available later in the day on October 26, 2023, continuing through November 26, 2023. To listen to it, please dial 1-877-344-7529 in
- About Bunge
At Bunge (NYSE: BG), our purpose is to connect farmers to consumers to deliver essential food, feed and fuel to the world. With more than two centuries of experience, unmatched global scale and deeply rooted relationships, we work to strengthen global food security, increase sustainability where we operate, and help communities prosper. As the world’s leader in oilseed processing and a leading producer and supplier of specialty plant-based oils and fats, we value our partnerships with farmers to bring quality products from where they’re grown to where they’re consumed. At the same time, we collaborate with our customers to develop tailored and innovative solutions to meet evolving dietary needs and trends in every part of the world. Our Company is headquartered in
- Website Information
We routinely post important information for investors on our website, www.bunge.com, in the "Investors" section. We may use this website as a means of disclosing material, non-public information and for complying with our disclosure obligations under Regulation FD. Accordingly, investors should monitor the Investors section of our website, in addition to following our press releases,
- Cautionary Statement Concerning Forward-Looking Statements
This press release contains both historical and forward-looking statements. All statements, other than statements of historical fact are, or may be deemed to be, forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (Exchange Act). These forward-looking statements are not based on historical facts, but rather reflect our current expectations and projections about our future results, performance, prospects and opportunities. We have tried to identify these forward-looking statements by using words including “may,” “will,” “should,” “could,” “expect,” “anticipate,” “believe,” “plan,” “intend,” “estimate,” “continue” and similar expressions. These forward-looking statements are subject to a number of risks, uncertainties, assumptions and other factors that could cause our actual results, performance, prospects or opportunities to differ materially from those expressed in, or implied by, these forward-looking statements. The following important factors, among others, could cause actual results to differ from these forward-looking statements: the impact on our employees, operations, and facilities from the war in
You should refer to “Item 1A. Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2022, filed with the SEC on February 24, 2023, “Risks Related to the Acquisition” and “Risks Related to the Redomestication” sections of the Company's definitive proxy statement filed with the SEC on August 7, 2023.
- Additional Financial Information
Certain gains and (charges), quarter-to-date
The following table provides a summary of certain gains and (charges) that may be of interest to investors, including a description of these items and their effect on Net income (loss) attributable to Bunge, Earnings per share diluted and Segment EBIT for the three month periods ended September 30, 2023 and 2022.
(US$ in millions, except per share data) |
Net Income (Loss)
|
Earnings
|
Segment
|
|||||||||||||||
Three Months Ended September 30, |
|
2023 |
|
|
2022 |
|
|
2023 |
|
|
2022 |
|
|
2023 |
|
|
2022 |
|
|
|
|
|
|
|
|
||||||||||||
Core Segments: |
$ |
9 |
|
$ |
(76 |
) |
$ |
0.06 |
|
$ |
(0.50 |
) |
$ |
10 |
|
$ |
(76 |
) |
Agribusiness |
$ |
9 |
|
$ |
(21 |
) |
$ |
0.06 |
|
$ |
(0.14 |
) |
$ |
10 |
|
$ |
(21 |
) |
Ukraine-Russia War |
|
9 |
|
|
— |
|
|
0.06 |
|
|
— |
|
|
10 |
|
|
— |
|
Impairment on sale of a business |
|
— |
|
|
(21 |
) |
|
— |
|
|
(0.14 |
) |
|
— |
|
|
(21 |
) |
|
|
|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
||||||||||||
Refined and Specialty Oils |
$ |
— |
|
$ |
(55 |
) |
$ |
— |
|
$ |
(0.36 |
) |
$ |
— |
|
$ |
(55 |
) |
Impairment on sale of a business |
|
— |
|
|
(55 |
) |
|
— |
|
|
(0.36 |
) |
|
— |
|
|
(55 |
) |
|
|
|
|
|
|
|
||||||||||||
Milling |
$ |
— |
|
$ |
— |
|
$ |
— |
|
$ |
— |
|
$ |
— |
|
$ |
— |
|
|
|
|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
||||||||||||
Corporate and Other: |
$ |
(67 |
) |
$ |
(41 |
) |
$ |
(0.44 |
) |
$ |
(0.27 |
) |
$ |
(68 |
) |
$ |
(11 |
) |
Acquisition and integration costs |
|
(47 |
) |
|
— |
|
|
(0.31 |
) |
|
— |
|
|
(48 |
) |
|
— |
|
Impairment of equity method and other investments |
|
(20 |
) |
|
— |
|
|
(0.13 |
) |
|
— |
|
|
(20 |
) |
|
— |
|
Impairment on sale of a business |
|
— |
|
|
(11 |
) |
|
— |
|
|
(0.07 |
) |
|
— |
|
|
(11 |
) |
Tax on |
|
— |
|
|
(30 |
) |
$ |
— |
|
|
(0.20 |
) |
|
— |
|
|
— |
|
|
|
|
|
|
|
|
||||||||||||
Non-core Segment: |
$ |
— |
|
$ |
— |
|
$ |
— |
|
$ |
— |
|
$ |
— |
|
$ |
— |
|
Sugar & Bioenergy |
$ |
— |
|
$ |
— |
|
$ |
— |
|
$ |
— |
|
$ |
— |
|
$ |
— |
|
|
|
|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
||||||||||||
Total |
$ |
(58 |
) |
$ |
(117 |
) |
$ |
(0.38 |
) |
$ |
(0.77 |
) |
$ |
(58 |
) |
$ |
(87 |
) |
See Definition and Reconciliation of Non-GAAP Measures. |
Core Segments
Agribusiness
EBIT for the three months ended September 30, 2023 included a mark-to-market gain of
EBIT for the three months ended September 30, 2022 included
Refined and Specialty Oils
EBIT for the three months ended September 30, 2022 included
Corporate and Other
Net income for the three months ended September 30, 2023 included
EBIT for the three months ended September 30, 2023 included a
EBIT for the three months ended September 30, 2022 included
Net income for the three months ended September 30, 2022 included
Certain gains and (charges), year-to-date
The following table provides a summary of certain gains and (charges) that may be of interest to investors, including a description of these items and their effect on Net income (loss) attributable to Bunge, Earnings per share diluted and Segment EBIT for the nine month periods ended September 30, 2023 and 2022.
|
|
|
|
|
|
|
||||||||||||
(US$ in millions, except per share data) |
Net Income (Loss) Attributable to Bunge |
Earnings Per Share Diluted |
Segment EBIT |
|||||||||||||||
Nine months ended September 30, |
|
2023 |
|
|
2022 |
|
|
2023 |
|
|
2022 |
|
|
2023 |
|
|
2022 |
|
|
|
|
|
|
|
|
||||||||||||
Core Segments: |
$ |
25 |
|
$ |
(144 |
) |
$ |
0.17 |
|
$ |
(0.95 |
) |
$ |
29 |
|
$ |
(156 |
) |
Agribusiness |
$ |
25 |
|
$ |
(89 |
) |
$ |
0.17 |
|
$ |
(0.59 |
) |
$ |
29 |
|
$ |
(101 |
) |
Ukraine-Russia War |
|
25 |
|
|
(68 |
) |
|
0.17 |
|
|
(0.45 |
) |
|
29 |
|
|
(80 |
) |
Impairment on sale of a business |
|
— |
|
|
(21 |
) |
|
— |
|
|
(0.14 |
) |
|
— |
|
|
(21 |
) |
|
|
|
|
|
|
|
||||||||||||
Refined and Specialty Oils |
$ |
— |
|
$ |
(55 |
) |
$ |
— |
|
$ |
(0.36 |
) |
$ |
— |
|
$ |
(55 |
) |
Impairment on sale of a business |
|
— |
|
|
(55 |
) |
|
— |
|
|
(0.36 |
) |
|
— |
|
|
(55 |
) |
|
|
|
|
|
|
|
||||||||||||
Milling |
$ |
— |
|
$ |
— |
|
$ |
— |
|
$ |
— |
|
$ |
— |
|
$ |
— |
|
|
|
|
|
|
|
|
||||||||||||
Corporate and Other: |
$ |
(109 |
) |
$ |
(59 |
) |
$ |
(0.72 |
) |
$ |
(0.37 |
) |
$ |
(102 |
) |
$ |
18 |
|
Acquisition and integration costs |
|
(73 |
) |
|
— |
|
|
(0.48 |
) |
|
— |
|
|
(66 |
) |
|
— |
|
Impairment of equity method and other investments |
|
(36 |
) |
|
— |
|
|
(0.24 |
) |
|
— |
|
|
(36 |
) |
|
— |
|
Pension settlement |
|
— |
|
|
21 |
|
|
— |
|
|
0.14 |
|
|
— |
|
|
29 |
|
Bond early redemption |
|
— |
|
|
(39 |
) |
|
— |
|
|
(0.25 |
) |
|
— |
|
|
— |
|
Impairment on sale of a business |
|
— |
|
|
(11 |
) |
|
— |
|
|
(0.07 |
) |
|
— |
|
|
(11 |
) |
Tax on |
|
— |
|
|
(30 |
) |
|
— |
|
|
(0.19 |
) |
|
— |
|
|
— |
|
|
|
|
|
|
|
|
||||||||||||
Non-core Segment: |
$ |
— |
|
$ |
— |
|
$ |
— |
|
$ |
— |
|
$ |
— |
|
$ |
— |
|
Sugar & Bioenergy |
$ |
— |
|
$ |
— |
|
$ |
— |
|
$ |
— |
|
$ |
— |
|
$ |
— |
|
|
|
|
|
|
|
|
||||||||||||
Total |
$ |
(84 |
) |
$ |
(203 |
) |
$ |
(0.55 |
) |
$ |
(1.32 |
) |
$ |
(73 |
) |
$ |
(138 |
) |
Core Segments
Agribusiness
EBIT for the nine months ended September 30, 2023 included a mark-to-market gain of
EBIT for the nine months ended September 30, 2022 included
EBIT for the nine months ended September 30, 2022 included
Refined and Specialty Oils
EBIT for the nine months ended September 30, 2022 included
Corporate and Other
Net income for the nine months ended September 30, 2023 included
EBIT for the nine months ended September 30, 2023 included a
EBIT for the nine months ended September 30, 2023 included a
EBIT for the nine months ended September 30, 2022 included a
Net income for the nine months ended September 30, 2022 also included
EBIT for the nine months ended September 30, 2022 included
Net income for the nine months ended September 30, 2022 included
- Consolidated Earnings Data (Unaudited)
|
Three Months Ended September 30, |
|
Nine Months Ended September 30, |
||||||||||
(US$ in millions, except per share data) |
|
2023 |
|
|
2022 |
|
|
|
2023 |
|
|
2022 |
|
Net sales |
$ |
14,227 |
|
$ |
16,759 |
|
|
$ |
44,604 |
|
$ |
50,572 |
|
Cost of goods sold |
|
(13,182 |
) |
|
(15,871 |
) |
|
|
(41,013 |
) |
|
(47,708 |
) |
Gross profit |
|
1,045 |
|
|
888 |
|
|
|
3,591 |
|
|
2,864 |
|
Selling, general and administrative expenses |
|
(447 |
) |
|
(337 |
) |
|
|
(1,220 |
) |
|
(979 |
) |
Foreign exchange (losses) gains |
|
(47 |
) |
|
(52 |
) |
|
|
(64 |
) |
|
(150 |
) |
Other income (expense) – net |
|
8 |
|
|
40 |
|
|
|
35 |
|
|
(13 |
) |
Income (loss) from affiliates |
|
39 |
|
|
30 |
|
|
|
83 |
|
|
95 |
|
EBIT attributable to noncontrolling interest (a) (1) |
|
(14 |
) |
|
(1 |
) |
|
|
(43 |
) |
|
(33 |
) |
Total Segment EBIT |
|
584 |
|
|
568 |
|
|
|
2,382 |
|
|
1,784 |
|
Interest income |
|
38 |
|
|
30 |
|
|
|
121 |
|
|
50 |
|
Interest expense |
|
(133 |
) |
|
(103 |
) |
|
|
(374 |
) |
|
(306 |
) |
Income tax (expense) benefit |
|
(114 |
) |
|
(113 |
) |
|
|
(495 |
) |
|
(257 |
) |
Noncontrolling interest share of interest and tax (a) (1) |
|
(2 |
) |
|
(2 |
) |
|
|
(7 |
) |
|
3 |
|
Net income (loss) attributable to Bunge (1) |
$ |
373 |
|
$ |
380 |
|
|
$ |
1,627 |
|
$ |
1,274 |
|
|
|
|
|
|
|
||||||||
Net income (loss) attributable to Bunge common shareholders - diluted |
$ |
2.47 |
|
$ |
2.49 |
|
|
$ |
10.71 |
|
$ |
8.30 |
|
Weighted–average common shares outstanding - diluted |
|
151 |
|
|
152 |
|
|
|
152 |
|
|
154 |
|
(a) The line items "EBIT attributable to noncontrolling interest" and "Noncontrolling interest share of interest and tax" when combined, represent consolidated Net (income) loss attributable to noncontrolling interests on a |
- Condensed Consolidated Balance Sheets (Unaudited)
|
September 30, |
|
December 31, |
||
(US$ in millions) |
|
2023 |
|
|
2022 |
Assets |
|
|
|
||
Cash and cash equivalents |
$ |
2,173 |
|
$ |
1,104 |
Trade accounts receivable, net |
|
2,509 |
|
|
2,829 |
Inventories (a) |
|
7,548 |
|
|
8,408 |
Assets held for sale |
|
1 |
|
|
36 |
Other current assets |
|
4,393 |
|
|
4,381 |
Total current assets |
|
16,624 |
|
|
16,758 |
Property, plant and equipment, net |
|
4,283 |
|
|
3,617 |
Operating lease assets |
|
864 |
|
|
1,024 |
Goodwill and other intangible assets, net |
|
889 |
|
|
830 |
Investments in affiliates |
|
1,201 |
|
|
1,012 |
Other non-current assets |
|
1,272 |
|
|
1,339 |
Total assets |
$ |
25,133 |
|
$ |
24,580 |
|
|
|
|
||
Liabilities and Equity |
|
|
|
||
Short-term debt |
$ |
914 |
|
$ |
546 |
Current portion of long-term debt |
|
301 |
|
|
846 |
Trade accounts payable |
|
3,975 |
|
|
4,386 |
Current operating lease obligations |
|
317 |
|
|
425 |
Liabilities held for sale |
|
— |
|
|
18 |
Other current liabilities |
|
2,738 |
|
|
3,379 |
Total current liabilities |
|
8,245 |
|
|
9,600 |
Long-term debt |
|
3,967 |
|
|
3,259 |
Non-current operating lease obligations |
|
495 |
|
|
547 |
Other non-current liabilities |
|
1,280 |
|
|
1,214 |
Total liabilities |
|
13,987 |
|
|
14,620 |
Redeemable noncontrolling interest |
|
3 |
|
|
4 |
Total equity |
|
11,143 |
|
|
9,956 |
Total liabilities, redeemable noncontrolling interest and equity |
$ |
25,133 |
|
$ |
24,580 |
(a) Includes readily marketable inventories of |
- Condensed Consolidated Statements of Cash Flows (Unaudited)
|
Nine Months Ended
|
||||||
(US$ in millions) |
|
2023 |
|
|
|
2022 |
|
Operating Activities |
|
|
|
||||
Net income (loss) (1) |
$ |
1,677 |
|
|
$ |
1,304 |
|
Adjustments to reconcile net income (loss) to cash provided by (used for) operating activities: |
|
|
|
||||
Impairment charges |
|
56 |
|
|
|
86 |
|
Foreign exchange (gain) loss on net debt |
|
(151 |
) |
|
|
(96 |
) |
Depreciation, depletion and amortization |
|
317 |
|
|
|
305 |
|
Deferred income tax expense (benefit) |
|
115 |
|
|
|
(92 |
) |
Results from affiliates |
|
(100 |
) |
|
|
(95 |
) |
Other, net |
|
116 |
|
|
|
150 |
|
Changes in operating assets and liabilities, excluding the effects of acquisitions: |
|
|
|
||||
Trade accounts receivable |
|
306 |
|
|
|
(359 |
) |
Inventories |
|
933 |
|
|
|
(229 |
) |
Secured advances to suppliers |
|
(228 |
) |
|
|
26 |
|
Trade accounts payable and accrued liabilities |
|
(690 |
) |
|
|
259 |
|
Advances on sales |
|
(227 |
) |
|
|
(81 |
) |
Net unrealized (gain) loss on derivative contracts |
|
(247 |
) |
|
|
(456 |
) |
Margin deposits |
|
(111 |
) |
|
|
(55 |
) |
Recoverable and income taxes, net |
|
(19 |
) |
|
|
(201 |
) |
Marketable securities |
|
(17 |
) |
|
|
341 |
|
Beneficial interest in securitized trade receivables (a) |
|
— |
|
|
|
(5,288 |
) |
Other, net |
|
130 |
|
|
|
(550 |
) |
Cash provided by (used for) operating activities |
|
1,860 |
|
|
|
(5,031 |
) |
Investing Activities |
|
|
|
||||
Payments made for capital expenditures |
|
(805 |
) |
|
|
(353 |
) |
Proceeds from investments |
|
21 |
|
|
|
217 |
|
Payments for investments |
|
(26 |
) |
|
|
(225 |
) |
Settlement of net investment hedges |
|
(57 |
) |
|
|
(153 |
) |
Proceeds from beneficial interest in securitized trade receivables (a) |
|
85 |
|
|
|
5,176 |
|
Proceeds from sales of businesses and property, plant and equipment |
|
165 |
|
|
|
496 |
|
Payments for investments in affiliates |
|
(136 |
) |
|
|
(55 |
) |
Other, net |
|
107 |
|
|
|
10 |
|
Cash provided by (used for) investing activities |
|
(646 |
) |
|
|
5,113 |
|
Financing Activities |
|
|
|
||||
Net borrowings (repayments) of short-term debt |
|
416 |
|
|
|
834 |
|
Net proceeds (repayments) of long-term debt |
|
96 |
|
|
|
(981 |
) |
Proceeds from the exercise of options for common shares |
|
7 |
|
|
|
30 |
|
Repurchases of common shares |
|
(466 |
) |
|
|
(200 |
) |
Dividends paid to common and preference shareholders |
|
(287 |
) |
|
|
(256 |
) |
Contributions from (Return of capital to) noncontrolling interest |
|
40 |
|
|
|
— |
|
Sale of noncontrolling interest |
|
— |
|
|
|
521 |
|
Acquisition of redeemable noncontrolling interest and noncontrolling interest |
|
— |
|
|
|
(102 |
) |
Other, net |
|
(19 |
) |
|
|
52 |
|
Cash provided by (used for) financing activities |
|
(213 |
) |
|
|
(102 |
) |
Effect of exchange rate changes on cash and cash equivalents, restricted cash, and cash held for sale |
|
40 |
|
|
|
112 |
|
Net increase (decrease) in cash and cash equivalents, restricted cash, and cash held for sale |
|
1,041 |
|
|
|
92 |
|
Cash and cash equivalents, restricted cash, and cash held for sale - beginning of period |
|
1,152 |
|
|
|
905 |
|
Cash and cash equivalents, restricted cash, and cash held for sale - end of period |
$ |
2,193 |
|
|
$ |
997 |
|
(a) See Quarter Results, Cash Flow Section for details regarding changes to the trade receivables securitization program. |
- Definition and Reconciliation of Non-GAAP Measures
This earnings release contains certain "non-GAAP financial measures" as defined in Regulation G of the Securities Exchange Act of 1934. Bunge has reconciled these non-GAAP financial measures to the most directly comparable
Total Segment EBIT and Adjusted Total Segment EBIT
Bunge uses segment earnings before interest and tax (“Segment EBIT”) to evaluate the operating performance of its individual segments. Segment EBIT excludes EBIT attributable to noncontrolling interests. Bunge also uses Core Segment EBIT, Non-Core Segment EBIT, Corporate and Other EBIT and Total Segment EBIT to evaluate the operating performance of Bunge’s Core reportable segments, Non-Core reportable segments and Total reportable segments together with Corporate and Other. Core Segment EBIT is the aggregate of the earnings before interest and taxes of each of Bunge’s Agribusiness, Refined and Specialty Oils, and Milling segments. Non-Core Segment EBIT is the earnings before interest and taxes of Bunge’s Sugar & Bioenergy segment. Total Segment EBIT is the aggregate of the earnings before interest and taxes of Bunge’s Core and Non-Core reportable segments, together with its Corporate and Other activities.
Adjusted Core Segment EBIT, Adjusted Non-Core Segment EBIT, Adjusted Corporate and Other EBIT and Adjusted Total Segment EBIT, are calculated by excluding temporary mark-to-market timing differences, as defined in note 3 below, and certain gains and (charges), as described in "Additional Financial Information" above, from Core Segment EBIT, Non-Core Segment EBIT, Corporate and Other EBIT, and Total Segment EBIT, respectively.
Core Segment EBIT, Non-Core Segment EBIT, Corporate and Other EBIT, Total Segment EBIT, Adjusted Core Segment EBIT, Adjusted Non-core Segment EBIT, Adjusted Corporate and Other EBIT and Adjusted Total Segment EBIT are non-GAAP financial measures and are not intended to replace Net income (loss) attributable to Bunge, the most directly comparable
Net Income (loss) attributable to Bunge to Adjusted Net Income (loss) attributable to Bunge
Adjusted Net Income (loss) excludes temporary mark-to-market timing differences, as defined in note 3 below, and certain gains and (charges), as described in "Additional Financial Information" above, and is a non-GAAP financial measure. This measure is not a measure of Net income (loss) attributable to Bunge, the most directly comparable
We also have presented projected Adjusted Net income per common share for 2023. This information is provided only on a non-GAAP basis without reconciliation to projected Net Income per common share for 2023, the mostly directly comparable
Below is a reconciliation of Net income attributable to Bunge, to Total Segment EBIT, and Adjusted Total Segment EBIT:
|
Three Months Ended
|
|
Nine Months Ended
|
||||||||||
(US$ in millions) |
|
2023 |
|
|
2022 |
|
|
|
2023 |
|
|
2022 |
|
Net income (loss) attributable to Bunge |
$ |
373 |
|
$ |
380 |
|
|
$ |
1,627 |
|
$ |
1,274 |
|
Interest income |
|
(38 |
) |
|
(30 |
) |
|
|
(121 |
) |
|
(50 |
) |
Interest expense |
|
133 |
|
|
103 |
|
|
|
374 |
|
|
306 |
|
Income tax expense (benefit) |
|
114 |
|
|
113 |
|
|
|
495 |
|
|
257 |
|
Noncontrolling interest share of interest and tax |
|
2 |
|
|
2 |
|
|
|
7 |
|
|
(3 |
) |
Total Segment EBIT |
$ |
584 |
|
$ |
568 |
|
|
$ |
2,382 |
|
$ |
1,784 |
|
|
|
|
|
|
|
||||||||
Agribusiness EBIT |
$ |
461 |
|
$ |
481 |
|
|
$ |
1,951 |
|
$ |
1,274 |
|
Refined and Specialty Oils EBIT |
|
227 |
|
|
128 |
|
|
|
677 |
|
$ |
519 |
|
Milling EBIT |
|
23 |
|
|
19 |
|
|
|
46 |
|
$ |
166 |
|
Core Segment EBIT |
$ |
711 |
|
$ |
628 |
|
|
$ |
2,674 |
|
$ |
1,959 |
|
|
|
|
|
|
|
||||||||
Corporate and Other EBIT |
$ |
(182 |
) |
$ |
(84 |
) |
|
$ |
(417 |
) |
$ |
(238 |
) |
|
|
|
|
|
|
||||||||
Sugar & Bioenergy EBIT |
$ |
55 |
|
$ |
24 |
|
|
$ |
125 |
|
$ |
63 |
|
Non-Core Segment EBIT |
$ |
55 |
|
$ |
24 |
|
|
$ |
125 |
|
$ |
63 |
|
|
|
|
|
|
|
||||||||
Total Segment EBIT |
$ |
584 |
|
$ |
568 |
|
|
$ |
2,382 |
|
$ |
1,784 |
|
Mark-to-market timing difference |
|
34 |
|
|
36 |
|
|
|
(261 |
) |
|
193 |
|
Certain (gains) & charges |
|
58 |
|
|
87 |
|
|
|
73 |
|
|
138 |
|
Adjusted Total Segment EBIT |
$ |
676 |
|
$ |
691 |
|
|
$ |
2,194 |
|
$ |
2,115 |
|
Below is a reconciliation of Net income (loss) attributable to Bunge, to Adjusted Net income (loss) attributable to Bunge:
|
Three Months Ended
|
|
Nine Months Ended
|
|||||||||
(US$ in millions, except per share data) |
|
2023 |
|
|
2022 |
|
|
2023 |
|
|
2022 |
|
Net income (loss) attributable to Bunge |
$ |
373 |
|
$ |
380 |
|
$ |
1,627 |
|
$ |
1,274 |
|
Mark-to-market timing difference |
|
21 |
|
|
29 |
|
|
(196 |
) |
|
160 |
|
Certain (gains) and charges: |
|
|
|
|
|
|||||||
Acquisition and integration costs |
|
47 |
|
|
— |
|
|
73 |
|
|
— |
|
Impairment of equity method and other investments |
|
20 |
|
|
— |
|
|
36 |
|
|
— |
|
|
|
(9 |
) |
|
— |
|
|
(25 |
) |
|
68 |
|
Bond early redemption |
|
— |
|
|
— |
|
|
— |
|
|
39 |
|
Impairment on sale of a business |
|
— |
|
|
87 |
|
|
— |
|
|
87 |
|
Pension settlement |
|
— |
|
|
— |
|
|
— |
|
|
(21 |
) |
Tax on |
|
— |
|
|
30 |
|
|
— |
|
|
30 |
|
Adjusted Net income (loss) attributable to Bunge |
$ |
452 |
|
$ |
526 |
|
$ |
1,515 |
|
$ |
1,637 |
|
Weighted-average common shares outstanding - diluted, adjusted (a) |
|
151 |
|
|
152 |
|
|
152 |
|
|
154 |
|
Adjusted Net income (loss) per common share - diluted |
$ |
2.99 |
|
$ |
3.45 |
|
$ |
9.97 |
|
$ |
10.66 |
|
(a) There were less than 1 million anti-dilutive outstanding stock options or contingently issuable restricted stock units excluded in the weighted-average number of common shares outstanding for each of the three and nine month periods ended September 30, 2023 and 2022. |
Adjusted Funds From Operations and Cash provided by (used for) operating activities, adjusted
Adjusted FFO is calculated by excluding from Cash provided by (used for) operating activities, foreign exchange gain (loss) on net debt, payments for beneficial interests in securitized trade receivables, working capital changes, net (income) loss attributable to noncontrolling interests and redeemable noncontrolling interests, and mark-to-market timing differences after tax. Adjusted FFO is a non-GAAP financial measure and is not intended to replace Cash provided by (used for) operating activities, the most directly comparable
Cash provided by (used for) operating activities, adjusted is calculated by including the Proceeds from beneficial interests in securitized trade receivables with Cash provided by (used for) operating activities. Cash provided by (used for) operating activities, adjusted is a non-GAAP financial measure and is not intended to replace Cash provided by (used for) operating activities, the most directly comparable
- Notes
(1) |
A reconciliation of Net income (loss) attributable to Bunge, to Net income (loss) is as follows: |
|
Three months ended September 30, |
|
Nine months ended September 30, |
|||||||
(US$ in millions) |
|
2023 |
|
2022 |
|
|
2023 |
|
2022 |
|
Net income (loss) attributable to Bunge |
$ |
373 |
$ |
380 |
|
$ |
1,627 |
$ |
1,274 |
|
EBIT attributable to noncontrolling interest |
|
14 |
|
1 |
|
|
43 |
|
33 |
|
Noncontrolling interest share of interest and tax |
|
2 |
|
2 |
|
|
7 |
|
(3 |
) |
Net income (loss) |
$ |
389 |
$ |
383 |
|
$ |
1,677 |
$ |
1,304 |
|
(2) |
The Processing business included in our Agribusiness segment consists of: global oilseed processing activities, which principally include the origination and crushing of oilseeds (including soybeans, canola, rapeseed and sunflower seed) into protein meals and vegetable oils; the distribution of oilseeds, oilseed products and fertilizer products through our port terminals and transportation assets (including trucks, railcars, barges and ocean vessels); fertilizer production; and biodiesel production, which is partially conducted through joint ventures. |
|
|
The Merchandising business included in our Agribusiness segment primarily consists of: global grain origination activities, which principally include the purchasing, cleaning, drying, storing and handling of corn, wheat and barley at our network of grain elevators; global trading and distribution of grains and oils; logistical services for the distribution of these commodities to our customer markets through our port terminals and transportation assets (including trucks, railcars, barges and ocean vessels); and financial services activities for customers from whom we purchase commodities, and other third parties. |
|
(3) |
Mark-to-market timing difference comprises the estimated net temporary impact resulting from unrealized period-end gains/losses associated with the fair valuation of certain forward contracts, readily marketable inventories (RMI), and related futures contracts associated with our committed future operating capacity. The impact of these mark-to-market timing differences, which is expected to reverse over time due to the forward contracts, RMI, and related futures contracts being part of an economically-hedged position, is not representative of the operating performance of our business. |
|
(4) |
A reconciliation of Cash provided by (used for) operating activities to Adjusted funds from operations (FFO) is as follows: |
|
Nine months ended September 30, |
||||||
(US$ in millions) |
|
2023 |
|
|
|
2022 |
|
Cash provided by (used for) operating activities |
$ |
1,860 |
|
|
$ |
(5,031 |
) |
Foreign exchange gain (loss) on net debt |
|
151 |
|
|
|
96 |
|
Beneficial interest in securitized trade receivables |
|
— |
|
|
|
5,288 |
|
Working capital changes |
|
170 |
|
|
|
1,305 |
|
Net (income) loss attributable to noncontrolling interests and redeemable noncontrolling interests |
|
(50 |
) |
|
|
(30 |
) |
Mark-to-Market timing difference, after tax |
|
(196 |
) |
|
|
160 |
|
Adjusted FFO |
$ |
1,935 |
|
|
$ |
1,788 |
|
(5) |
We have not presented a comparable |
View source version on businesswire.com: https://www.businesswire.com/news/home/20231026324795/en/
Investor Contact:
Ruth Ann Wisener
Bunge Limited
636-292-3014
ruthann.wisener@bunge.com
Media Contact:
Bunge News Bureau
Bunge Limited
636-292-3022
news@bunge.com
Source: Bunge Limited
FAQ
What were Bunge's Q3 2023 GAAP diluted EPS?
What were Bunge's adjusted Q3 2023 EPS?
What progress has Bunge made on the Viterra transaction?
Has Bunge repurchased any common shares?
What is Bunge's updated full-year adjusted EPS outlook?
